ACSL1 exhibits elevated expression levels in hepatocellular carcinoma, BC, ovarian cancer, and colorectal cancer, while displays low expression in esophageal adenocarcinoma and renal cell carcinoma (Zhang and Wang, 2023). This evidence concerns the gene ACSL1 and ovarian cancer.